Taula de Continguts
- What is GLP-1 treatment and how does it work?
- Who is GLP-1 treatment indicated for?
- What are the differences between Ozempic, Wegovy, and Mounjaro?
- What to expect during GLP-1 treatment?
- Treatment results and timeline
- Contraindications and precautions
- How Santé Clínica Estética approaches it
- Key points
- Frequently asked questions
What is GLP-1 treatment and how does it work?
Treatment with GLP-1 (glucagon-like peptide-1) receptor agonists is a medical strategy for weight control. These drugs mimic a natural hormone that regulates appetite and satiety. By doing so, they contribute to a controlled reduction in caloric intake.
GLP-1 medications, such as semaglutide (found in Ozempic and Wegovy) or tirzepatide (Mounjaro), act in the brain to decrease hunger. They also slow gastric emptying, which prolongs the feeling of fullness. This dual mechanism facilitates gradual and sustained weight loss.
Who is GLP-1 treatment indicated for?
GLP-1 treatment is indicated for adults with overweight or obesity who have not achieved significant weight loss with diet and exercise. The decision to start this treatment is always made after a thorough medical evaluation. It is essential to establish whether the patient meets the clinical criteria.
At Santé Clínica Estética, we prioritize the individual assessment of each case. Our medical team determines the suitability of the treatment, considering the patient's health history and specific goals. It is not a universal solution, but a tool within a comprehensive health plan.
What are the differences between Ozempic, Wegovy, and Mounjaro?
Ozempic, Wegovy, and Mounjaro are medications that act on the GLP-1 system, but they have some key differences. Ozempic and Wegovy contain semaglutide, while Mounjaro uses tirzepatide. Tirzepatide is a dual agonist that acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, which may offer a more pronounced effect in some cases.
Although both are effective for weight control, their formulation, dosage, and availability may vary. The choice of the specific drug depends on the medical evaluation and the patient's individual response. The most appropriate and safest option is always sought.
| Drug | Active Ingredient | Main Mechanism | Main Indication |
|---|---|---|---|
| Ozempic | Semaglutide | GLP-1 Agonist | Type 2 Diabetes (also used off-label for weight) |
| Wegovy | Semaglutide | GLP-1 Agonist | Weight management in overweight/obesity |
| Mounjaro | Tirzepatide | GLP-1 and GIP Agonist | Type 2 Diabetes (also used off-label for weight) |
What to expect during GLP-1 treatment?
GLP-1 treatment is administered via subcutaneous injections, usually once a week. The dose is gradually increased under medical supervision to minimize potential side effects. This adjustment process is crucial for tolerance and effectiveness.
The most common side effects include nausea, vomiting, diarrhea, or constipation, especially at the beginning of treatment. These are usually transient and improve as the body adapts. Regular medical follow-up allows for managing any symptoms and adjusting the plan if necessary.
Clinical studies have shown that patients using semaglutide (Wegovy) can achieve an average weight loss of 15% of their initial body weight in approximately 68 weeks, when combined with lifestyle changes.
Treatment results and timeline
The results of GLP-1 treatment are not immediate but develop progressively. Weight loss usually begins in the first few weeks and continues steadily for several months. The assessment of the final result is carried out after an adequate and sustained treatment period.
It is important to remember that individual results can vary significantly. The success of the treatment largely depends on adherence to the medical plan and lifestyle recommendations. Weight loss is a process that requires commitment and patience.
- Initial Medical Consultation
- Suitability Assessment
- Initiation of GLP-1 Treatment
- Gradual Dose Increase
- Monthly Follow-up with Nutritionist
- Progress Evaluation (3-6 months)
- Plan Adjustment if Necessary
- Maintenance and Continuous Follow-up
Contraindications and precautions
Although GLP-1 treatment is safe for many people, there are some important contraindications. It is not recommended for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It is also not advised during pregnancy and breastfeeding.
Other precautions include patients with pancreatitis or severe kidney disease. Therefore, a rigorous medical evaluation is essential before starting any treatment. Patient safety is our top priority at Santé Clínica Estética.
How Santé Clínica Estética approaches it
At Santé Clínica Estética, GLP-1 treatment is integrated into a holistic and personalized weight management program. Our approach begins with a detailed initial medical consultation (€50), where one of our licensed doctors will evaluate your clinical history. A complete analytical panel will be performed, and your health goals will be discussed.
Our medical team, led by Dr. Sol Monsalve, will design a protocol tailored to your needs. This includes the prescription and adjustment of GLP-1 medication, as well as continuous follow-up with a nutritionist (€50) to optimize results. Follow-up consultations at two weeks are included at no additional cost.
We are proud to offer quality care in a premium environment on Avenida Diagonal in Barcelona. Our multilingual staff serves in Spanish, English, Portuguese, and Russian. Transparency in pricing and clear communication are pillars of our philosophy.
Key points
- GLP-1 treatment is a medical option for weight loss, mimicking hormones that regulate appetite.
- It requires strict medical supervision to assess suitability and safely adjust the dose.
- Ozempic, Wegovy, and Mounjaro are GLP-1 drugs with slight differences in composition and action.
- Results are gradual and are assessed over several months, being individual for each patient.
- Contraindications include certain family or personal history of thyroid cancer and pregnancy.
- Santé Clínica Estética offers a comprehensive medical GLP-1 program with nutritional follow-up.
Frequently asked questions
Is GLP-1 treatment a quick solution for weight loss?
No, GLP-1 treatment is not a quick solution. It is a gradual process that requires commitment and develops over weeks and months. Optimal results are achieved in combination with lifestyle changes, such as diet and exercise.
Can I buy GLP-1 medications without a prescription?
No, GLP-1 medications such as Ozempic, Wegovy, or Mounjaro are prescription-only drugs. Their use without professional supervision can be dangerous and is not recommended at all. Medical evaluation and follow-up are essential.
What happens if I stop GLP-1 treatment?
If GLP-1 treatment is interrupted without a maintenance strategy, it is possible to regain some of the lost weight. Therefore, the discontinuation of treatment is carefully planned with the medical team. The goal is to consolidate healthy habits and maintain the achieved weight long-term.
How much does GLP-1 treatment cost at Santé Clínica Estética?
The cost of GLP-1 treatment at Santé Clínica Estética is €400 for medical supervision and the follow-up program. This price does not include the cost of the medication itself, which is purchased at a pharmacy with a medical prescription. The initial medical and nutritional consultations each cost €50.
